Company / Capital Returned to Shareholders
Henry Schein Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$850.0M
FY2025
5-year range
$385.0M / $850.0M
FY2021-FY2025
Trend
+120.8%
vs FY2024
Sector context
#24 of 108
Health Care
What the data says
Henry Schein's capital returned to shareholders of $850M is higher than 78% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders returned to growth in FY2025 after 2 years of decline, reaching $850M.
Based on SEC 10-K filings.
$850M in FY2025 with a 5-year CAGR of +62.9%. Top quartile in the Health Care sector.
Improved from $401M to $850M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +20.6%
- 5-Year CAGR
- +62.9%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 108This company $850.0M Sector average $754.9M
▼
+12.6% above sector average
Key checks
Key Insights
- 5-year CAGR of +62.9%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 120.8% year-over-year.
- Ranks #24 out of 108 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2020.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $850.0M | +120.8% |
| FY2024 | $385.0M | -4.0% |
| FY2023 | $401.0M | -17.3% |
| FY2022 | $485.0M | +20.9% |
| FY2021 | $401.0M | +441.9% |
| FY2020 | $74.0M | -83.6% |
| FY2019 | $450.0M | +125.0% |
| FY2018 | $200.0M | -55.6% |
| FY2017 | $450.0M | -18.2% |
| FY2016 | $550.0M | +83.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026